BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report)’s share price was up 2.9% during mid-day trading on Tuesday . The stock traded as high as C$5.27 and last traded at C$5.24. 3,387 shares changed hands during trading, a decline of 83% from the average session volume of 19,511 shares. The stock had previously closed at C$5.09.
BriaCell Therapeutics Stock Up 2.9%
The stock has a market cap of C$45.59 million, a PE ratio of -6.24 and a beta of 1.98. The firm has a fifty day moving average of C$4.68 and a 200 day moving average of C$5.67.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
